Pricing Log in Create free account

ArriVent BioPharma, Inc. (AVBP) vs Cybin Inc. (HELP)

ArriVent BioPharma, Inc. and Cybin Inc. are both Biotechnology companies. ArriVent BioPharma, Inc. and Cybin Inc. are of similar size ($827.9M and $807.3M). Across the 9 metrics below, ArriVent BioPharma, Inc. leads on 7 and Cybin Inc. on 2.

Valuation

Metric AVBP HELP Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.16 2.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (21.73%) (38.49%) (33.15%)
Free cash flow yield (18.65%) (25.89%) (25.50%)

Profitability

Metric AVBP HELP Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (53.10%) (86.94%) (56.36%)
Return on assets (49.30%) (72.78%) (48.04%)
Return on invested capital 0.00% (137.88%) 0.00%

Growth

Metric AVBP HELP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (68.75%) (5.72%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AVBP HELP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.16 10.97 4.72
Net debt to EBITDA 1.73 1.10 0.96

Dividend

Metric AVBP HELP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVBP HELP Biotechnology median
Market cap 827.88m 807.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack